Pliant Therapeutics, Inc. (PLRX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Pliant Therapeutics, Inc. presented at the RBC Capital Markets Global Healthcare Conference on May 19, 2026. The presentation featured insights from President and CEO Bernard Coulie regarding the company's recent dose escalation data. The discussion highlighted ongoing enthusiasm for their treatment program based on patient responses and follow-up results.
- ▪Pliant Therapeutics, Inc. is listed under the ticker symbol PLRX.
- ▪The presentation took place at the RBC Capital Markets Global Healthcare Conference.
- ▪Bernard Coulie, the President and CEO, discussed recent updates on dose escalation data.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4908144-pliant-therapeutics-inc-plrx-presents-at-rbc-capital-markets-global-healthcare-conference"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
